Guizhou Tianan Pharmaceutical

Guizhou Tianan Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the research, development, and manufacturing of medications for diabetes and its complications. As a subsidiary of China Resources Double-Crane Pharmaceutical, the company has established a strong market presence with its portfolio of oral hypoglycemic agents, including metformin, glimepiride, and pioglitazone. Beyond blood glucose management, the company is recognized for its expertise in treating diabetic microvascular lesions using products like calcium dobesilate. Guizhou Tianan operates modern manufacturing facilities in Guiyang and continues to expand its pipeline through bioequivalence studies for newer generation anti-diabetics such as dapagliflozin. The company integrates R&D, production, and sales to provide comprehensive health solutions for chronic metabolic diseases.